| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |